Effective July 1, 2026

Medical Pharmacy Drug List (MPDL) for Sparx Participants

Sparx is committed to supporting participating organizations and providers with tools and resources that promote consistency, transparency, and informed decision-making in medical pharmacy management. As specialty pharmaceuticals and provider-administered therapies continue to evolve, maintaining an accurate and current reference source is essential for navigating product availability, coding requirements, and therapeutic options.

The Medical Pharmacy Drug List (MDPL) serves as a reference guide for medically administered therapies and includes products organized by therapeutic category with associated HCPCS coding information. The MDPL is intended to assist providers and participating organizations in identifying available therapies while supporting alignment with current FDA approvals, clinical evidence, and Medicare program requirements.

Loading the drug list…